UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Sie befinden Sich nicht im Netzwerk der Universität Paderborn. Der Zugriff auf elektronische Ressourcen ist gegebenenfalls nur via VPN oder Shibboleth (DFN-AAI) möglich. mehr Informationen...

Identification of ABX-1431, a Selective Inhibitor of Monoacylglycerol Lipase and Clinical Candidate for Treatment of Neurological Disorders

Journal of medicinal chemistry, 2018-10, Vol.61 (20), p.9062-9084

2018

Link zum Volltext

Verfügbarkeit prüfen

Prasugrel versus Clopidogrel for Acute Coronary Syndromes without Revascularization

The New England journal of medicine, 2012-10, Vol.367 (14), p.1297-1309

2012

Link zum Volltext

Verfügbarkeit prüfen

Virological and immunological impact of integrase inhibitor-based regimens initiated during primary HIV-1 infection

AIDS (London), 2020-03, Vol.34 (4), p.493-500

2020

Link zum Volltext

Verfügbarkeit prüfen

Activity-Based Protein Profiling Delivers Selective Drug Candidate ABX-1431, a Monoacylglycerol Lipase Inhibitor, To Control Lipid Metabolism in Neurological Disorders

Journal of medicinal chemistry, 2018-10, Vol.61 (20), p.9059-9061

2018

Link zum Volltext

Verfügbarkeit prüfen

The Discovery of LML134, a Histamine H3 Receptor Inverse Agonist for the Clinical Treatment of Excessive Sleep Disorders

ChemMedChem, 2019-07, Vol.14 (13), p.1238-1247

2019

Link zum Volltext

Verfügbarkeit prüfen

Sildenafil for pulmonary hypertension in neonates

Cochrane database of systematic reviews, 2007-07 (3), p.CD005494

2007

Link zum Volltext

Verfügbarkeit prüfen

Psychosocial interventions for erectile dysfunction

Cochrane database of systematic reviews, 2007-07 (3), p.CD004825

2007

Link zum Volltext

Verfügbarkeit prüfen

Adjuvant imatinib treatment improves recurrence-free survival in patients with high-risk gastrointestinal stromal tumours (GIST)

British journal of cancer, 2007-06, Vol.96 (11), p.1656-1658

2007

Link zum Volltext

Verfügbarkeit prüfen

Cellular Source and Amount of Vascular Endothelial Growth Factor and Platelet-Derived Growth Factor in Tumors Determine Response to Angiogenesis Inhibitors

Cancer research (Chicago, Ill.), 2009-05, Vol.69 (10), p.4527-4536

2009

Link zum Volltext

Verfügbarkeit prüfen

Olaparib for Metastatic Castration-Resistant Prostate Cancer

The New England journal of medicine, 2020-05, Vol.382 (22), p.2091-2102

2020

Link zum Volltext

Verfügbarkeit prüfen

TBCRC 048: Phase II Study of Olaparib for Metastatic Breast Cancer and Mutations in Homologous Recombination-Related Genes

Journal of clinical oncology, 2020-12, Vol.38 (36), p.4274-4282

2020

Link zum Volltext

Verfügbarkeit prüfen

Haloperidol and Ziprasidone for Treatment of Delirium in Critical Illness

The New England journal of medicine, 2018-12, Vol.379 (26), p.2506-2516

2018

Link zum Volltext

Verfügbarkeit prüfen

Olaparib Versus Nonplatinum Chemotherapy in Patients With Platinum-Sensitive Relapsed Ovarian Cancer and a Germline BRCA1/2 Mutation (SOLO3): A Randomized Phase III Trial

Journal of clinical oncology, 2020-04, Vol.38 (11), p.1164-1174

2020

Link zum Volltext

Verfügbarkeit prüfen

Ferroptosis Inducers Are a Novel Therapeutic Approach for Advanced Prostate Cancer

Cancer research (Chicago, Ill.), 2021-03, Vol.81 (6), p.1583-1594

2021

Link zum Volltext

Verfügbarkeit prüfen

Adjuvant Olaparib for Patients with BRCA1- or BRCA2-Mutated Breast Cancer

The New England journal of medicine, 2021-06, Vol.384 (25), p.2394-2405

2021

Link zum Volltext

Verfügbarkeit prüfen

Sotorasib for Lung Cancers with KRAS p.G12C Mutation

The New England journal of medicine, 2021-06, Vol.384 (25), p.2371-2381

2021

Link zum Volltext

Verfügbarkeit prüfen

Osimertinib in Untreated EGFR-Mutated Advanced Non–Small-Cell Lung Cancer

The New England journal of medicine, 2018-01, Vol.378 (2), p.113-125

2018

Link zum Volltext

Verfügbarkeit prüfen

Imidazole Ketone Erastin Induces Ferroptosis and Slows Tumor Growth in a Mouse Lymphoma Model

Cell chemical biology, 2019-05, Vol.26 (5), p.623-633.e9

2019

Link zum Volltext

Verfügbarkeit prüfen

Phase II Study of AZD4547 in Patients With Tumors Harboring Aberrations in the FGFR Pathway: Results From the NCI-MATCH Trial (EAY131) Subprotocol W

Journal of clinical oncology, 2020-07, Vol.38 (21), p.2407-2417

2020

Link zum Volltext

Verfügbarkeit prüfen

Survival with Olaparib in Metastatic Castration-Resistant Prostate Cancer

The New England journal of medicine, 2020-12, Vol.383 (24), p.2345-2357

2020

Link zum Volltext

Verfügbarkeit prüfen

Maintenance Olaparib in Patients with Newly Diagnosed Advanced Ovarian Cancer

The New England journal of medicine, 2018-12, Vol.379 (26), p.2495-2505

2018

Link zum Volltext

Verfügbarkeit prüfen

A decade of clinical development of PARP inhibitors in perspective

Annals of oncology, 2019-09, Vol.30 (9), p.1437-1447

2019

Link zum Volltext

Verfügbarkeit prüfen

Sotorasib: First Approval

Drugs (New York, N.Y.), 2021-09, Vol.81 (13), p.1573-1579

Blair, Hannah A.

2021

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 16.767

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(14.160)
Mit Volltextzugriff
(11.288)

Publikationsform

Sprache

Englisch
(14.578)
Japanisch
(2.005)
Französisch
(458)
Deutsch
(451)
Chinesisch
(244)
Russisch
(198)
Italienisch
(194)
Spanisch
(153)
Portugiesisch
(95)
Polnisch
(71)
Ungarisch
(41)
Niederländisch
(36)
Tschechisch
(27)
Dänisch
(24)
Schwedisch
(22)
Norwegisch
(14)
Rumänisch
(14)
Finnisch
(11)
Bulgarisch
(10)
Hebräisch
(10)

15 weitere anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

Humans
(15.129)
Piperazines - Therapeutic Use
(14.825)
Science & Technology
(12.094)
Life Sciences & Biomedicine
(11.893)
Male
(8.562)
Female
(6.871)
Middle Aged
(5.622)
Adult
(5.189)
Imatinib Mesylate
(5.151)
Pyrimidines - Therapeutic Use
(5.097)
Benzamides
(4.354)
Antineoplastic Agents - Therapeutic Use
(3.916)
Biological And Medical Sciences
(3.699)
Aged
(3.682)
Medical Sciences
(3.645)
Treatment Outcome
(3.243)
Piperazines - Adverse Effects
(2.966)
Animals
(2.965)
Oncology
(2.835)
Piperazines - Pharmacology
(2.721)

15 weitere anzeigen...

Weniger anzeigen...

Kollektion

Ovid SocietyJournals and Single Titles
(6.650)
Ingenta
(6.444)
EZB Free E-Journals
(6.344)
Single Journals
(3.772)
IngentaConnect Journals
(3.185)
Elsevier ScienceDirect Journals Complete
(2.938)
Wiley Blackwell Single Titles
(2.005)
Elsevier Journal Backfiles on ScienceDirect (DFG Nationallizenzen)
(2.003)
SpringerNature Journals
(1.519)
Wiley Online Library
(1.421)
SpringerLINK Contemporary (Konsortium Baden-Württemberg)
(942)
Taylor & Francis Current Content Access
(766)
Taylor & Francis Journals Complete
(728)
Nature Journals
(682)
Oxford University Press Journals Current
(580)
Nexis Uni
(548)
EBSCOhost Psychology and Behavioral Sciences Collection
(381)
Oxford Journals 2020 Medicine
(356)
SAGE Publications
(332)
Thieme Connect Journals
(219)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

Blood
(256)
The Journal Of Clinical Psychiatry
(223)
Leukemia Research
(199)
Leukemia
(195)
Journal Of Clinical Psychopharmacology
(146)
Clinical Cancer Research
(143)
Journal Of Sexual Medicine
(141)
Journal Of Clinical Oncology
(140)
Leukemia & Lymphoma
(138)
The New England Journal Of Medicine
(130)

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(12)
... seit 90 Tagen
(44)

Menü

Weitere Dienste

Einstellungen

Identification of ABX-1431, a Selective Inhibitor of Monoacylglycerol Lipase and Clinical Candidate for Treatment of Neurological Disorders

Prasugrel versus Clopidogrel for Acute Coronary Syndromes without Revascularization

Virological and immunological impact of integrase inhibitor-based regimens initiated during primary HIV-1 infection

Activity-Based Protein Profiling Delivers Selective Drug Candidate ABX-1431, a Monoacylglycerol Lipase Inhibitor, To Control Lipid Metabolism in Neurological Disorders

Evolving concepts in the management of chronic myeloid leukemia: recommendations from an expert panel on behalf of the European LeukemiaNet

The Discovery of LML134, a Histamine H3 Receptor Inverse Agonist for the Clinical Treatment of Excessive Sleep Disorders

Sildenafil for pulmonary hypertension in neonates

Psychosocial interventions for erectile dysfunction

Adjuvant imatinib treatment improves recurrence-free survival in patients with high-risk gastrointestinal stromal tumours (GIST)

The clinical KRAS(G12C) inhibitor AMG 510 drives anti-tumour immunity

Cellular Source and Amount of Vascular Endothelial Growth Factor and Platelet-Derived Growth Factor in Tumors Determine Response to Angiogenesis Inhibitors

Olaparib for Metastatic Castration-Resistant Prostate Cancer

TBCRC 048: Phase II Study of Olaparib for Metastatic Breast Cancer and Mutations in Homologous Recombination-Related Genes

Haloperidol and Ziprasidone for Treatment of Delirium in Critical Illness

Olaparib Versus Nonplatinum Chemotherapy in Patients With Platinum-Sensitive Relapsed Ovarian Cancer and a Germline BRCA1/2 Mutation (SOLO3): A Randomized Phase III Trial

Ferroptosis Inducers Are a Novel Therapeutic Approach for Advanced Prostate Cancer

Adjuvant Olaparib for Patients with BRCA1- or BRCA2-Mutated Breast Cancer

Sotorasib for Lung Cancers with KRAS p.G12C Mutation

Osimertinib in Untreated EGFR-Mutated Advanced Non–Small-Cell Lung Cancer

Imidazole Ketone Erastin Induces Ferroptosis and Slows Tumor Growth in a Mouse Lymphoma Model

Phase II Study of AZD4547 in Patients With Tumors Harboring Aberrations in the FGFR Pathway: Results From the NCI-MATCH Trial (EAY131) Subprotocol W

Survival with Olaparib in Metastatic Castration-Resistant Prostate Cancer

Maintenance Olaparib in Patients with Newly Diagnosed Advanced Ovarian Cancer

A decade of clinical development of PARP inhibitors in perspective

Sotorasib: First Approval

Suchergebnisse filtern